• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment
Commentary on: Hayes JH, Ollendorf DA, Pearson SD, et al.. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Ann Intern Med 2013;158:853–60. Context What is the best treatment for localised prostate cancer? This simple question, for a common disease now affecting about one in six North American men, does not have a clear answer. This is not a ‘normal’ situation in medicine. For most common diseases, including most primary cancers, there is usually a consensus as to the best therapeutic approach. Not so for localised prostate cancer. Surge...
Source: Evidence-Based Medicine - January 22, 2014 Category: Internal Medicine Authors: Klotz, L. Tags: Epidemiologic studies, Stroke, Screening (oncology), Radiology, Surgical diagnostic tests, Clinical diagnostic tests, Prostate Economic analysis Source Type: research